Severe Viral Lung Infections clinical trials

Explore recruiting severe viral lung infections clinical trials.

Recruiting severe viral lung infections studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Severe Viral Lung Infections trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase III, Multicentre, Randomised, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Tozorakimab (MEDI3506) in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen (TILIA)

France, Sweden, Bulgaria, Romania, Greece, Italy +8 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Severe Viral Lung Infections trials by city

Severe Viral Lung Infections clinical trials

Recruiting severe viral lung infections studies right now

Convalescent Plasma as a Possible Treatment for COVID-19

Defibrotide for the Treatment of Severe COVID-19

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Uterine Blood Mesenchymal Stem Cells Injection for the Treatment of Severe Pneumonia Caused by Viruses

IMPACT-D+: Immune-Modulating and Psychometric Effects of Accelerated TMS in Depression Plus Comorbid Post-COVID-19 Condition

Severe COVID-19 Infection in Children Presenting to EDs in Israel and England

Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19

The Role of Obesity in Severe COVID-19 Pathophysiology

Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants

EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease

Imaging Immune Activation in COVID-19

The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill Patients

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

Also recruiting in Europe

A Phase III, Multicentre, Randomised, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Tozorakimab (MEDI3506) in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen (TILIA)

Severe Viral Lung Infections trials by city

Other conditions